MA
AZN icon

MONECO Advisors’s AstraZeneca AZN Stock Holding History

MONECO Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$638K Buy
3,235
+148
+5% +$28.5K 0.05% 265
2025
Q4 		$568K Sell
3,087
-21
-0.7% -$3.68K 0.05% 284
2025
Q3 		$477K Buy
3,108
+1,428
+85% +$216K 0.04% 312
2025
Q2 		$235K Sell
1,680
-45
-3% -$6.31K 0.02% 427
2025
Q1 		$253K Sell
1,725
-24
-1% -$3.47K 0.03% 397
2024
Q4 		$229K Buy
1,749
+343
+24% +$48K 0.02% 424
2024
Q3 		$219K Buy
1,406
+110
+8% +$17.8K 0.03% 404
2024
Q2 		$202K Buy
+1,296
New +$195K 0.03% 409

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

MONECO Advisors's AZN Position: Q1 2026 in Review

MONECO Advisors increased its AstraZeneca (AZN) stake by 4.8% in Q1 2026, buying an estimated $28.5K and bringing the position to 3,235 shares worth $638K. The position accounts for 0.05% of the portfolio, ranked #265.

MONECO Advisors first reported a position in AZN in Q2 2024 and has held it in 8 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • MONECO Advisors held 3,235 shares of AstraZeneca worth $638K as of Q1 2026.
  • MONECO Advisors bought 148 AstraZeneca shares in Q1 2026, an estimated $28.5K.
  • AstraZeneca made up 0.05% of MONECO Advisors's portfolio in Q1 2026, its #265 holding.
  • MONECO Advisors first reported a position in AstraZeneca in Q2 2024 and has held it in 8 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on MONECO Advisors's 13F filing for Q1 2026, filed 8 May 2026.